ZUSDURI: Mitomycin Hydrogel for Bladder Chemoablation
An educational profile of ZUSDURI, a mitomycin hydrogel for intravesical chemoablation of low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC). Updated with 2026 J-code reimbursement, UGN-103 UTOPIA trial results, and commercial launch data.